Tumor Cell Selectivity

Tumor Cell Selectivity is a biological targeting metric that distinguishes the preferential uptake or binding of Auger electron-emitting radiopharmaceuticals by tumor cells relative to surrounding healthy tissues, based on molecular, metabolic, or receptor-specific differences.

651

Publications

38.5K

Citations

4.4K

Authors

1.1K

Institutions

Publications per year

2017–2026

218

Authors

4.4K

  1. HS
    Hiroshi Sakagami

    Meikai University, Japan

    9 publications · 220 citations

    9

    h-index

  2. HF
    Heinz‐Herbert Fiebig

    University of Freiburg, Germany

    5 publications · 346 citations

    5

    h-index

  3. MJ
    Michael J. Rishel

    GE Global Research (United States), United States

    5 publications · 504 citations

    5

    h-index

  4. CW
    Chaojie Wang

    Henan University, China

    5 publications · 194 citations

    5

    h-index

  5. KT
    Koichi Takao

    Josai University, Japan

    5 publications · 73 citations

    5

    h-index

1–5 of 4.4K

Venues

  1. PubMed

    Repository · 61 publications · 5.5K citations

    39

    h-index

  2. Cancer Research

    26 publications · 2.9K citations

    26

    h-index

  3. Journal of Medicinal Chemistry

    21 publications · 1.5K citations

    20

    h-index

  4. Molecular Cancer Therapeutics

    MCT · 17 publications · 1.4K citations

    16

    h-index

  5. Clinical Cancer Research

    15 publications · 1K citations

    15

    h-index

1–5